Projecting the potential impact of an Omicron XBB.1.5 wave in Shanghai, China

Author:

Liu Hengcong,Xu Xiangyanyu,Deng Xiaowei,Hu Zexin,Sun Ruijia,Zou Junyi,Dong Jiayi,Wu Qianhui,Chen Xinhua,Yi Lan,Cai JunORCID,Zhang Juanjuan,Ajelli Marco,Yu Hongjie

Abstract

AbstractChina experienced a major nationwide wave of SARS-CoV-2 infections in December 2022, immediately after lifting strict interventions, despite the majority of the population having already received inactivated COVID-19 vaccines. Due to the rapid waning of protection and the emergence of Omicron XBB.1.5, the risk of another COVID-19 wave remains high. It is still unclear whether the health care system will be able to manage the demand during this potential XBB.1.5 wave and if the number of associated deaths can be reduced to a level comparable to that of seasonal influenza. Thus, we developed a mathematical model of XBB.1.5 transmission using Shanghai as a case study. We found that a potential XBB.1.5 wave is less likely to overwhelm the health care system and would result in a death toll comparable to that of seasonal influenza, albeit still larger, especially among elderly individuals. Our analyses show that a combination of vaccines and antiviral drugs can effectively mitigate an XBB.1.5 epidemic, with a projected number of deaths of 2.08 per 10,000 individuals.This figure corresponds to a 70–80% decrease compared to the previous Omicron wave and is comparable to the level of seasonal influenza. The peak prevalence of hospital admissions and ICU admissions are projected at 28.89 and 2.28 per 10,000 individuals, respectively, suggesting the need for a moderate increase in the capacity of the health care system. Our findings emphasize the importance of improving vaccination coverage, particularly among the older population, and the use of antiviral treatments.

Publisher

Cold Spring Harbor Laboratory

Reference44 articles.

1. Chinese Center for Disease Control and Prevention. COVID-19 Clinical and Surveillance Data — December 9, 2022 to April 27,2023, China. [cited 2023 April 27]; Available from: https://weekly.chinacdc.cn/fileCCDCW/cms/news/info/upload//e712e241-fbcb-426b-9ac8-551ce6fd7ccc.pdf

2. Xinhua. China Focus: China releases measures to optimize COVID-19 response. [cited 2023 April 11]; Available from: https://english.news.cn/20221111/d4399114a082438eaac32d08a02bf58d/c.html.

3. Xinhua. China Focus: COVID-19 response further optimized with 10 new measures. [cited 2023 April 11]; Available from: https://english.news.cn/20221207/ca014c043bf24728b8dcbc0198565fdf/c.html.

4. Gang Lu, Y.L. , Minghao Jiang , Yun Tan , Dong Wei , Lu Jiang , Shuting Yu , Fangying Jiang , Shuai Wang , Yao Dai , Jinzeng Wang , Geng Wu , Xinxin Zhang , Guoyu Meng , Shengyue Wang , Feng Liu , Xiaohong Fan , Saijuan Chen , Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland. Front. Med., 2022.

5. Leung, K. , et al.,. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after the adjustment of zero-COVID policy in November - December 2022. Nat Med, 2023.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3